514 related articles for article (PubMed ID: 25690647)
1. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype.
Du T; Yu X; Zhang J; Sun X
Acta Diabetol; 2015 Oct; 52(5):855-63. PubMed ID: 25690647
[TBL] [Abstract][Full Text] [Related]
2. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
3. Comparison of novel visceral obesity indexes with traditional obesity measurements in predicting of metabolically unhealthy nonobese phenotype in hemodialysis patients.
Zhou C; Peng Y; Jiang W; Yuan J; Zha Y
BMC Endocr Disord; 2021 Dec; 21(1):244. PubMed ID: 34923974
[TBL] [Abstract][Full Text] [Related]
4. LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY.
Xie X; Li Q; Zhang L; Ren W
Endocr Pract; 2018 Jan; 24(1):33-39. PubMed ID: 29144802
[TBL] [Abstract][Full Text] [Related]
5. Visceral, general, abdominal adiposity and atherogenic index of plasma in relatively lean hemodialysis patients.
Zhou C; Peng H; Yuan J; Lin X; Zha Y; Chen H
BMC Nephrol; 2018 Aug; 19(1):206. PubMed ID: 30115010
[TBL] [Abstract][Full Text] [Related]
6. Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?
Kavaric N; Klisic A; Ninic A
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28632304
[TBL] [Abstract][Full Text] [Related]
7. Visceral Adiposity Index and Lipid Accumulation Product Index: Two Alternate Body Indices to Identify Chronic Kidney Disease among the Rural Population in Northeast China.
Dai D; Chang Y; Chen Y; Chen S; Yu S; Guo X; Sun Y
Int J Environ Res Public Health; 2016 Dec; 13(12):. PubMed ID: 27983609
[TBL] [Abstract][Full Text] [Related]
8. Comparison of visceral, general and central obesity indices in the prediction of metabolic syndrome in maintenance hemodialysis patients.
Zhou C; Zhan L; Yuan J; Tong X; Peng Y; Zha Y
Eat Weight Disord; 2020 Jun; 25(3):727-734. PubMed ID: 30968371
[TBL] [Abstract][Full Text] [Related]
9. Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes.
Ahn N; Baumeister SE; Amann U; Rathmann W; Peters A; Huth C; Thorand B; Meisinger C
Sci Rep; 2019 Jul; 9(1):9693. PubMed ID: 31273286
[TBL] [Abstract][Full Text] [Related]
10. Adiposity phenotypes are associated with type-2 diabetes: LAP index, body adiposity index, and neck circumference.
Marcadenti A; Fuchs FD; Moreira LB; Gus M; Fuchs SC
Atherosclerosis; 2017 Nov; 266():145-150. PubMed ID: 29028482
[TBL] [Abstract][Full Text] [Related]
11. The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.
Wang H; Cao H; Cao J; Zhang L
Biomed Res Int; 2023; 2023():1508675. PubMed ID: 36814799
[TBL] [Abstract][Full Text] [Related]
12. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
13. Lipid accumulation product and visceral adiposity ındex: two new indices to predict metabolic syndrome in chronic kidney disease.
Biyik Z; Guney I
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2167-2173. PubMed ID: 30915762
[TBL] [Abstract][Full Text] [Related]
14. Association of lipid accumulation product and visceral adiposity index with the risk of hypertension among oil workers in Xinjiang, China.
Muheiyati G; Mei Y; Tao N
PeerJ; 2023; 11():e15273. PubMed ID: 37214102
[TBL] [Abstract][Full Text] [Related]
15. Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009.
Du T; Sun X; Huo R; Yu X
Int J Obes (Lond); 2014 Jun; 38(6):840-7. PubMed ID: 24048141
[TBL] [Abstract][Full Text] [Related]
16. Importance of Measured Body Fat, Visceral Adiposity Index, and Lipid Accumulation Product Index in Predicting Cardiometabolic Risk Factors.
Demirbas N; Kutlu R
Metab Syndr Relat Disord; 2021 Apr; 19(3):174-179. PubMed ID: 33121374
[No Abstract] [Full Text] [Related]
17. Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype.
Kang YM; Jung CH; Cho YK; Jang JE; Hwang JY; Kim EH; Lee WJ; Park JY; Kim HK
PLoS One; 2017; 12(6):e0179635. PubMed ID: 28644850
[TBL] [Abstract][Full Text] [Related]
18. The application of visceral adiposity index in identifying type 2 diabetes risks based on a prospective cohort in China.
Chen C; Xu Y; Guo ZR; Yang J; Wu M; Hu XS
Lipids Health Dis; 2014 Jul; 13():108. PubMed ID: 25002013
[TBL] [Abstract][Full Text] [Related]
19. Comparison of anthropometric indices for predicting the risk of metabolic syndrome and its components in Chinese adults: a prospective, longitudinal study.
Wang H; Liu A; Zhao T; Gong X; Pang T; Zhou Y; Xiao Y; Yan Y; Fan C; Teng W; Lai Y; Shan Z
BMJ Open; 2017 Sep; 7(9):e016062. PubMed ID: 28928179
[TBL] [Abstract][Full Text] [Related]
20. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference.
Wan H; Wang Y; Xiang Q; Fang S; Chen Y; Chen C; Zhang W; Zhang H; Xia F; Wang N; Lu Y
Cardiovasc Diabetol; 2020 Jul; 19(1):118. PubMed ID: 32736628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
